The Goldman Sachs Group Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $57.00
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price objective cut by The Goldman Sachs Group from $66.00 to $57.00 ...
The Goldman Sachs Group Cuts Kraft Heinz (NASDAQ:KHC) Price Target to $28.00
Kraft Heinz (NASDAQ:KHC – Free Report) had its price target reduced by The Goldman Sachs Group from $32.00 to $28.00 in a ...
KCE: An Attractive Investment Option For Lofty Returns As Capital Markets Poised To Mark New Records
KCE ETF has outperformed the S&P 500, offering a solid dividend yield and a low expense ratio. Read why KCE is recommended ...